Assessment of cytokine expression profile in acute myeloid leukemia patients before and after chemotherapy;Akut myeloid lösemi hastalari{dotless}nda kemoterapi öncesi ve sonrasi{dotless} dönemdeki sitokin ekspresyon profilinin deǧerlendirilmesi

Turkish Journal of Hematology

Volumn 31, Issue 2, 2014, Pages 149-154

  Sepehrizadeh, Zargham ^a   Mohammadi, Mohammad ^a   Emami, Amirhossein ^a   Yazdi, Mojtaba Tabatabaei ^a   Bozchlou, Saeed Hashemi ^a   Khorramizadeh, Mohammad Reza ^a   Shapourabadi, Mina Bahrololoumi ^a   Jaberi, Elham ^a   Rajaei, Naghmeh ^a   Setayesh, Neda ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute myeloid leukemia; Cytokines; Granulocyte colony stimulating factor; RT PCR

Indexed keywords

CYTARABINE; CYTOKINE; FLUDARABINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOXANTRONE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DENSITOMETRY; FEMALE; GENE EXPRESSION; HUMAN; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SINGLE DRUG DOSE;

EID: 84905914440     PISSN: 13007777     EISSN: 13085263     Source Type: Journal    
DOI: 10.4274/tjh.2012.0164     Document Type: Article

References (22)

1. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukemia. Crit Rev Oncol Hematol 2004;50:197-222.
2. Ersvær E, Hampson P, Hatfield K, Ulvestad E, Wendelbo Ø, Lord JM, Gjertsen BT, Bruserud Ø. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005. Cancer Immunol Immunother 2006;56:913-925.
3. Baraldi-Junkines CA, Beek AC, Rothstein G. Hematopoiesis and cytokines. Hematol Oncol Clin Amer 2000;14:45-61.
4. Stevens DL. Cytokines: an updated compendium. Current Opin Inf Dis 1995;8:175-180.
5. Ihle JN. Cytokine receptor signaling. Nature 1994;377:591-594.
6. Bellanti JA, Kadlec JV, Escobar-Gutierrez A. Cytokines and the immune response. Pediatr Clin North Am 1994;41:597-621.
7. Borish L, Rossenwasser LJ. Update on cytokines. J Allergy Clin Immunol 1996;97:719-734.
8. Young D, Griffin J. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986;68:1178-1181.
9. Bradbury D, Bowen G, Kozlowski R, Reilly I, Russell N. Endogenous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF. Leukemia 1990;4:44-47.
10. Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 1989;8:451-457.
11. Tobler A, Moser B, Dewald B, Geiser T, Studer H, Baggiolini M, Fey MF. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood 1993;82:2517-2525.
12. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6- type cytokine signaling and its regulation. Biochem J 2003;374:1-20.
13. Houssiau FA, Schandene L, Stevens M, Cambiaso C, Goldman M, Van Snick J, Renauld JC. A cascade of cytokines is responsible for IL-9 expression in human T cell. Involvement of IL-2, IL-4 and IL-10. J Immunol 1995;154:2624-2630.
14. Tan J, Deleuran B, Gesser B, Maare H, Deleuran M, Larsen CG, Thestrup-Pedersen K. Regulation of human T lymphocytes chemotaxis in vitro by T cell derived cytokines IL-2, IFN-γ, IL-4, IL-10, and IL-13. J Immunol 1995;154:3742-3752.
15. Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996;62:61-130.
16. Bach EA, Aguet M, Schreiber RD. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 1997;15:563-591.
17. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.
18. Ezaki K. Cytokine therapy for hematological malignancies. Int J Hematol 1996;65:17-29.
19. Bates RC, Mercurio AM. Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 2003;14:1790-1800.
20. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U. Imbalanced intrahepatic expression of interleukin 12, interferon γ, and interleukin 10 in fulminant hepatitis B. Hepatology 2002;36:1001-1008.
21. Reddy VB, Oelschlager DK, Nolan JS, Taylor KL, Post J, Grizzle WE, Manne U. Cytokine expression profiles of patients with acute myelogenous leukemia (AML) and non-Hodgkin lymphoma (NHL) detected by multiplex assay. J Clin Oncol ASCO Annual Meeting Proceedings (Post- Meeting Edition) 2007;25:18530.
22. Gao XZ, Bi S, Copra H, Devemy E, Venugopal P, Li B, Hsu WT, Loew J, Galvez A, Gregory S, Yang J, Horvath E, Preisler HD. Cytokine gene activity in AML cells in vivo in patients. Leuk Res 1998;22:429-438.